Skip to main content
SpringerLink
Log in
Book cover

The Diabetic Foot pp 17–32Cite as

Epidemiology and Health Care Cost of Diabetic Foot Problems

  • Chapter
  • First Online:

Part of the book series: Contemporary Diabetes ((CDI))

Abstract

In 1992, Zimmet first referred to the “epidemic of diabetes,” noting that its costs both in terms of economic burden and human suffering are rising at an alarming rate (Zimmet, Diabetes Care. 1992;15(2):232–52). The global prevalence of diabetes mellitus has been projected to nearly double from a baseline of 2.8% in 2000 to 4.4% by 2030, affecting over 350 million individuals (Wild et al. Diabetes Care. 2004;27(5):1047–53). In the decade beginning in 1997, the prevalence of diabetes in the USA has increased by 48% (http://apps.nccd.cdc.gov/DDTSTRS/default.aspx) (Fig. 2.1). Lower extremity morbidity contributes substantially to the toll diabetes takes on the individual and the health care system. This chapter focuses on the epidemiologic aspects of risk factors and complications in the diabetic lower extremity, particularly as they relate to the outcome of amputation. Included in the discussion is the influence of demographic factors, such as gender, age, race, and socioeconomic considerations, as well as the cost to the health care system of lower extremity disease in diabetes.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   219.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Zimmet PZ. Kelly West Lecture 1991. Challenges in diabetes epidemiology—from West to the rest. Diabetes Care. 1992;15(2):232–52.

    PubMed  CAS  Google Scholar 

  2. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047–53.

    Article  PubMed  Google Scholar 

  3. Centers for Disease Control and Prevention (CDC). Diabetes Data and Trends. http://apps.nccd.cdc.gov/DDTSTRS/default.aspx. Updated 2010. Accessed August 30, 2010.

  4. LeQuesne P, Parkshouse N, Faris I. Neuropathy. In: Faris I, editor. The management of the diabetic foot. 2nd ed. Edinburgh: Churchill Livingstone; 1991. p. 41.

    Google Scholar 

  5. Dyck PJ, Kratz KM, Karnes JL, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology. 1993;43(4):817–24.

    Article  PubMed  CAS  Google Scholar 

  6. Maser RE, Steenkiste AR, Dorman JS, et al. Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes. 1989;38(11):1456–61.

    Article  PubMed  CAS  Google Scholar 

  7. Young MJ, Boulton AJ, MacLeod AF, Williams DR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia. 1993;36(2):150–4.

    Article  PubMed  CAS  Google Scholar 

  8. Tesfaye S, Stevens LK, Stephenson JM, et al. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM complications study. Diabetologia. 1996;39(11):1377–84.

    Article  PubMed  CAS  Google Scholar 

  9. Walters DP, Gatling W, Mullee MA, Hill RD. The prevalence of diabetic distal sensory neuropathy in an English community. Diabet Med. 1992;9(4):349–53.

    Article  PubMed  CAS  Google Scholar 

  10. Gregg EW, Sorlie P, Paulose-Ram R, et al. Prevalence of lower-extremity disease in the US adult population >=40 years of age with and without diabetes: 1999-2000 national health and nutrition examination survey. Diabetes Care. 2004;27(7):1591–7.

    Article  PubMed  Google Scholar 

  11. Gregg EW, Gu Q, Williams D, et al. Prevalence of lower extremity diseases associated with normal glucose levels, impaired fasting glucose, and diabetes among U.S. adults aged 40 or older. Diabetes Res Clin Pract. 2007;77(3):485–8.

    Article  PubMed  CAS  Google Scholar 

  12. Centers for Disease Control and Prevention (CDC). Hospitalizations for lower extremity conditions. http://www.cdc.gov/diabetes/statistics/hospitalization_national.htm. Updated 2007. Accessed May 30, 2010.

  13. Cutting K. Glossary. In: Miller M, Glover G, editors. Wound management theory and practice. London: Johnson & Johnson Medical; 1999. p. 170.

    Google Scholar 

  14. Edmonds M, Foster A, editors. The high-risk foot. In: Managing the diabetic foot. London: Blackwell Science; 2000. p. 35–44.

    Google Scholar 

  15. Daousi C, MacFarlane IA, Woodward A, Nurmikko TJ, Bundred PE, Benbow SJ. Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes. Diabet Med. 2004;21(9):976–82.

    Article  PubMed  CAS  Google Scholar 

  16. Hall GC, Carroll D, Parry D, McQuay HJ. Epidemiology and treatment of neuropathic pain: the UK primary care perspective. Pain. 2006;122(1–2):156–62.

    Article  PubMed  Google Scholar 

  17. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977–86.

    Article  Google Scholar 

  18. Partanen J, Niskanen L, Lehtinen J, Mervaala E, Siitonen O, Uusitupa M. Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. N Engl J Med. 1995;333(2):89–94.

    Article  PubMed  CAS  Google Scholar 

  19. Faris I. Vascular disease. In: Faris I, editor. The management of the diabetic foot. 2nd ed. Edinburgh: Churchill Livingstone; 1991. p. 9.

    Google Scholar 

  20. Abbott RD, Brand FN, Kannel WB. Epidemiology of some peripheral arterial findings in diabetic men and women: experiences from the Framingham Study. Am J Med. 1990;88(4):376–81.

    Article  PubMed  CAS  Google Scholar 

  21. Abbott CA, Carrington AL, Ashe H, et al. The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet Med. 2002;19(5):377–84.

    Article  PubMed  CAS  Google Scholar 

  22. Boyko EJ, Ahroni JH, Cohen V, Nelson KM, Heagerty PJ. Prediction of diabetic foot ulcer occurrence using commonly available clinical information: the Seattle Diabetic Foot Study. Diabetes Care. 2006;29(6):1202–7.

    Article  PubMed  Google Scholar 

  23. Grant WP, Sullivan R, Sonenshine DE, et al. Electron microscopic investigation of the effects of diabetes mellitus on the Achilles tendon. J Foot Ankle Surg. 1997;36(4):272–8; discussion 330.

    Article  PubMed  CAS  Google Scholar 

  24. Reddy GK. Cross-linking in collagen by nonenzymatic glycation increases the matrix stiffness in rabbit Achilles tendon. Exp Diabesity Res. 2004;5(2):143–53.

    Article  PubMed  CAS  Google Scholar 

  25. Reddy GK. Glucose-mediated in vitro glycation modulates biomechanical integrity of the soft tissues but not hard tissues. J Orthop Res. 2003;21(4):738–43.

    Article  PubMed  Google Scholar 

  26. Reiber GE, Vileikyte L, Boyko EJ, et al. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care. 1999;22(1):157–62.

    Article  PubMed  CAS  Google Scholar 

  27. Masson EA, Hay EM, Stockley I, Veves A, Betts RP, Boulton AJ. Abnormal foot pressures alone may not cause ulceration. Diabet Med. 1989;6(5):426–8.

    Article  PubMed  CAS  Google Scholar 

  28. Moss SE, Klein R, Klein BE. The 14-year incidence of lower-extremity amputations in a diabetic population. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Diabetes Care. 1999;22(6):951–9.

    Article  PubMed  CAS  Google Scholar 

  29. Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321(7258):405–12.

    Article  PubMed  CAS  Google Scholar 

  30. Dorsey RR, Eberhardt MS, Gregg EW, Geiss LS. Control of risk factors among people with diagnosed diabetes, by lower extremity disease status. Prev Chronic Dis. 2009;6(4):A114.

    PubMed  Google Scholar 

  31. Schaper NC. Diabetic foot ulcer classification system for research purposes: a progress report on criteria for including patients in research studies. Diabetes Metab Res Rev. 2004;20 Suppl 1:S90–5.

    Article  PubMed  Google Scholar 

  32. Lavery LA, Armstrong DG, Wunderlich RP, Tredwell J, Boulton AJ. Predictive value of foot pressure assessment as part of a population-based diabetes disease management program. Diabetes Care. 2003;26(4):1069–73.

    Article  PubMed  Google Scholar 

  33. Ramsey SD, Newton K, Blough D, et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care. 1999;22(3):382–7.

    Article  PubMed  CAS  Google Scholar 

  34. Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA. 2005;293(2):217–28.

    Article  PubMed  CAS  Google Scholar 

  35. Apelqvist J, Larsson J, Agardh CD. Long-term prognosis for diabetic patients with foot ulcers. J Intern Med. 1993;233(6):485–91.

    Article  PubMed  CAS  Google Scholar 

  36. Mantey I, Foster AV, Spencer S, Edmonds ME. Why do foot ulcers recur in diabetic patients? Diabet Med. 1999;16(3):245–9.

    Article  PubMed  CAS  Google Scholar 

  37. Chantelau E, Kushner T, Spraul M. How effective is cushioned therapeutic footwear in protecting diabetic feet? A clinical study. Diabet Med. 1990;7(4):355–9.

    Article  PubMed  CAS  Google Scholar 

  38. Pound N, Chipchase S, Treece K, Game F, Jeffcoate W. Ulcer-free survival following management of foot ulcers in diabetes. Diabet Med. 2005;22(10):1306–9.

    Article  PubMed  CAS  Google Scholar 

  39. Ali SM, Fareed A, Humail SM, et al. The personal cost of diabetic foot disease in the developing world—a study from Pakistan. Diabet Med. 2008;25(10):1231–3.

    Article  PubMed  CAS  Google Scholar 

  40. Gershater MA, Londahl M, Nyberg P, et al. Complexity of factors related to outcome of neuropathic and neuroischaemic/ischaemic diabetic foot ulcers: a cohort study. Diabetologia. 2009;52(3):398–407.

    Article  PubMed  CAS  Google Scholar 

  41. Moulik PK, Mtonga R, Gill GV. Amputation and mortality in new-onset diabetic foot ulcers stratified by etiology. Diabetes Care. 2003;26(2):491–4.

    Article  PubMed  Google Scholar 

  42. Reiber GE, Lipsky BA, Gibbons GW. The burden of diabetic foot ulcers. Am J Surg. 1998;176(2A Suppl):5S–10.

    Article  PubMed  CAS  Google Scholar 

  43. Apelqvist J, Bakker K, van Houtum WH, Nabuurs-Franssen MH, Schaper NC. International consensus and practical guidelines on the management and the prevention of the diabetic foot. International Working Group on the Diabetic Foot. Diabetes Metab Res Rev. 2000;16 Suppl 1:S84–92.

    Article  PubMed  Google Scholar 

  44. Lavery LA, Armstrong DG, Wunderlich RP, Mohler MJ, Wendel CS, Lipsky BA. Risk factors for foot infections in individuals with diabetes. Diabetes Care. 2006;29(6):1288–93.

    Article  PubMed  Google Scholar 

  45. Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation. Basis for prevention. Diabetes Care. 1990;13(5):513–21.

    Article  PubMed  CAS  Google Scholar 

  46. Margolis DJ, Allen-Taylor L, Hoffstad O, Berlin JA. Diabetic neuropathic foot ulcers and amputation. Wound Repair Regen. 2005;13(3):230–6.

    Article  PubMed  Google Scholar 

  47. Peters EJ, Lavery LA, International Working Group on the Diabetic Foot. Effectiveness of the diabetic foot risk classification system of the International Working Group on the Diabetic Foot. Diabetes Care. 2001;24(8):1442–7.

    Article  PubMed  CAS  Google Scholar 

  48. Schade CP, Hannah KL. Quality of ambulatory care for diabetes and lower-extremity amputation. Am J Med Qual. 2007;22(6):410–7.

    Article  PubMed  Google Scholar 

  49. Schofield CJ, Libby G, Brennan GM, et al. Mortality and hospitalization in patients after amputation: a comparison between patients with and without diabetes. Diabetes Care. 2006;29(10):2252–6.

    Article  PubMed  Google Scholar 

  50. Siitonen OI, Niskanen LK, Laakso M, Siitonen JT, Pyorala K. Lower-extremity amputations in diabetic and nondiabetic patients. A population-based study in eastern Finland. Diabetes Care. 1993;16(1):16–20.

    Article  PubMed  CAS  Google Scholar 

  51. Trautner C, Haastert B, Giani G, Berger M. Incidence of lower limb amputations and diabetes. Diabetes Care. 1996;19(9):1006–9.

    Article  PubMed  CAS  Google Scholar 

  52. Willrich A, Pinzur M, McNeil M, Juknelis D, Lavery L. Health related quality of life, cognitive function, and depression in diabetic patients with foot ulcer or amputation. A preliminary study. Foot Ankle Int. 2005;26(2):128–34.

    PubMed  Google Scholar 

  53. Agency for Healthcare Research and Quality. 2009 State Snapshots. Updated 2009. Accessed August 30, 2010.

    Google Scholar 

  54. Centers for Disease Control and Prevention (CDC). Healthy people 2010 midcourse review. http://www.healthypeople.gov/Data/midcourse/pdf/fa05.pdf. Updated 2007. Accessed June 20, 2010.

  55. Alexandrescu V, Hubermont G, Coessens V, et al. Why a multidisciplinary team may represent a key factor for lowering the inferior limb loss rate in diabetic neuro-ischaemic wounds: application in a departmental institution. Acta Chir Belg. 2009;109(6):694–700.

    PubMed  CAS  Google Scholar 

  56. Drach-Zahavy A, Shadmi E, Freund A, Goldfracht M. High quality diabetes care: testing the effectiveness of strategies of regional implementation teams. Int J Health Care Qual Assur. 2009;22(7):709–27.

    Article  PubMed  Google Scholar 

  57. Sumpio BE, Armstrong DG, Lavery LA, Andros G, SVS/APMA Writing Group. The role of interdisciplinary team approach in the management of the diabetic foot: a joint statement from the Society for Vascular Surgery and the American Podiatric Medical Association. J Vasc Surg. 2010;51(6):1504–6.

    Article  PubMed  Google Scholar 

  58. Moxey PW, Hofman D, Hinchliffe RJ, Jones K, Thompson MM, Holt PJ. Epidemiological study of lower limb amputation in England between 2003 and 2008. Br J Surg. 2010;97(9):1348–53.

    Article  PubMed  CAS  Google Scholar 

  59. Resnick HE, Carter EA, Sosenko JM, et al. Incidence of lower-extremity amputation in American Indians: the Strong Heart Study. Diabetes Care. 2004;27(8):1885–91.

    Article  PubMed  Google Scholar 

  60. Centers for Disease Control and Prevention (CDC). CDC WONDER Data. http://wonder.cdc.gov/data2010/. Updated 2010. Accessed July 10, 2010.

  61. Agency for Healthcare Research and Quality. 2008 National Healthcare Quality & Disparities Reports. http://www.ahrq.gov/qual/qrdr08.htm#toc. Updated 2008. Accessed Aug 10, 2010.

  62. U.S. Census Bureau. American Community Survey Web site. http://www.census.gov/acs/www/. Updated 2004. Accessed August 30, 2010.

  63. Wrobel JS, Charns MP, Diehr P, et al. The relationship between provider coordination and diabetes-related foot outcomes. Diabetes Care. 2003;26(11):3042–7.

    Article  PubMed  Google Scholar 

  64. Resnick HE, Valsania P, Phillips CL. Diabetes mellitus and nontraumatic lower extremity amputation in black and white Americans: the National Health and Nutrition Examination Survey Epidemiologic Follow-up Study, 1971-1992. Arch Intern Med. 1999;159(20):2470–5.

    Article  PubMed  CAS  Google Scholar 

  65. Agency for Healthcare Research and Quality. HCUP Quality Indicators Archive. AHRQ Quality Indicators, Rockville, MD. http://www.qualityindicators.ahrq.gov/hcup_archive.htm. Updated 2004. Accessed May 10, 2010.

  66. Izumi Y, Satterfield K, Lee S, Harkless LB, Lavery LA. Mortality of first-time amputees in diabetics: a 10-year observation. Diabetes Res Clin Pract. 2009;83(1):126–31.

    Article  PubMed  Google Scholar 

  67. Izumi Y, Satterfield K, Lee S, Harkless LB. Risk of reamputation in diabetic patients stratified by limb and level of amputation: a 10-year observation. Diabetes Care. 2006;29(3):566–70.

    Article  PubMed  Google Scholar 

  68. Tseng CL, Helmer D, Rajan M, et al. Evaluation of regional variation in total, major, and minor amputation rates in a national health-care system. Int J Qual Health Care. 2007;19(6):368–76.

    Article  PubMed  Google Scholar 

  69. Apelqvist J, Ragnarson-Tennvall G, Larsson J, Persson U. Long-term costs for foot ulcers in diabetic patients in a multidisciplinary setting. Foot Ankle Int. 1995; 16(7):388–94.

    PubMed  CAS  Google Scholar 

  70. Edmonds M, Foster A. Ulcer-free survival in diabetic foot patients. Diabet Med. 2005;22(10):1293–4.

    Article  PubMed  CAS  Google Scholar 

  71. Aulivola B, Hile CN, Hamdan AD, et al. Major lower extremity amputation: outcome of a modern series. Arch Surg. 2004;139(4):395–9; discussion 399.

    Article  PubMed  Google Scholar 

  72. Kald A, Carlsson R, Nilsson E. Major amputation in a defined population: incidence, mortality and results of treatment. Br J Surg. 1989;76(3):308–10.

    Article  PubMed  CAS  Google Scholar 

  73. Kazmers A, Perkins AJ, Jacobs LA. Major lower extremity amputation in Veterans Affairs Medical Centers. Ann Vasc Surg. 2000;14(3):216–22.

    Article  PubMed  CAS  Google Scholar 

  74. Peng CW, Tan SG. Perioperative and rehabilitative outcomes after amputation for ischaemic leg gangrene. Ann Acad Med Singapore. 2000;29(2): 168–72.

    PubMed  CAS  Google Scholar 

  75. Subramaniam B, Pomposelli F, Talmor D, Park KW. Perioperative and long-term morbidity and mortality after above-knee and below-knee amputations in diabetics and nondiabetics. Anesth Analg. 2005;100(5): 1241–7. Table of contents.

    Article  PubMed  Google Scholar 

  76. Lavery LA, Peters EJ, Armstrong DG, Wendel CS, Murdoch DP, Lipsky BA. Risk factors for developing osteomyelitis in patients with diabetic foot wounds. Diabetes Res Clin Pract. 2009;83(3):347–52.

    Article  PubMed  Google Scholar 

  77. Stone PA, Flaherty SK, Hayes JD, AbuRahma AF. Lower extremity amputation: a contemporary series. W V Med J. 2007;103(5):14–8.

    PubMed  Google Scholar 

  78. Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J. The global burden of diabetic foot disease. Lancet. 2005;366(9498):1719–24.

    Article  PubMed  Google Scholar 

  79. Prompers L, Huijberts M, Schaper N, et al. Resource utilisation and costs associated with the treatment of diabetic foot ulcers. Prospective data from the Eurodiale Study. Diabetologia. 2008;51(10):1826–34.

    Article  PubMed  CAS  Google Scholar 

  80. Harrington C, Zagari MJ, Corea J, Klitenic J. A cost analysis of diabetic lower-extremity ulcers. Diabetes Care. 2000;23(9):1333–8.

    Article  PubMed  CAS  Google Scholar 

  81. Ramsey SD, Newton K, Blough D, McCulloch DK, Sandhu N, Wagner EH. Patient-level estimates of the cost of complications in diabetes in a managed-care population. Pharmacoeconomics. 1999;16(3):285–95.

    Article  PubMed  CAS  Google Scholar 

  82. Stockl K, Vanderplas A, Tafesse E, Chang E. Costs of lower-extremity ulcers among patients with diabetes. Diabetes Care. 2004;27(9):2129–34.

    Article  PubMed  Google Scholar 

  83. Apelqvist J. Wound healing in diabetes. Outcome and costs. Clin Podiatr Med Surg. 1998;15(1):21–39.

    PubMed  CAS  Google Scholar 

  84. Apelqvist J, Ragnarson-Tennvall G, Persson U, Larsson J. Diabetic foot ulcers in a multidisciplinary setting. An economic analysis of primary healing and healing with amputation. J Intern Med. 1994;235(5):463–71.

    Article  PubMed  CAS  Google Scholar 

  85. Holzer SE, Camerota A, Martens L, Cuerdon T, Crystal-Peters J, Zagari M. Costs and duration of care for lower extremity ulcers in patients with diabetes. Clin Ther. 1998;20(1):169–81.

    Article  PubMed  CAS  Google Scholar 

  86. Van Acker K, Oleen-Burkey M, De Decker L, et al. Cost and resource utilization for prevention and treatment of foot lesions in a diabetic foot clinic in Belgium. Diabetes Res Clin Pract. 2000;50(2):87–95.

    Article  PubMed  Google Scholar 

  87. Ragnarson Tennvall G, Apelqvist J. Health-economic consequences of diabetic foot lesions. Clin Infect Dis. 2004;39 Suppl 2:S132–9.

    Article  PubMed  Google Scholar 

  88. Agency for Healthcare Research and Quality. Measuring healthcare quality. http://www.ahrq.gov/qual/measurix.htm. Updated 2009. Accessed Aug 30, 2010.

  89. McCabe CJ, Stevenson RC, Dolan AM. Evaluation of a diabetic foot screening and protection programme. Diabet Med. 1998;15(1):80–4.

    Article  PubMed  CAS  Google Scholar 

  90. Habacher W, Rakovac I, Görzer E, Haas W, Gfrerer RJ, Wach P, Pieber TR. A model to analyse costs and benefit of intensified diabetic foot care in Austria. J Eval Clin Pract. 2007;13:906–12.

    PubMed  Google Scholar 

  91. Li R, Zhang P, Barker LE, Chowdhury FM, Zhang X. Cost-effectiveness of interventions to prevent and control diabetes mellitus: a systematic review. Diabetes Care. 2010;33(8):1872–94.

    Article  PubMed  Google Scholar 

  92. Ortegon MM, Redekop WK, Niessen LW. Cost-effectiveness of prevention and treatment of the diabetic foot: a Markov analysis. Diabetes Care. 2004;27(4):901–7.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Mount Auburn Hospital, Harvard Medical School, 330 Mount Auburn Street, Cambridge, MA, 02138, USA

    Jeremy J. Cook DPM, MPH, CPH, FACFAS

  2. Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA

    Donald C. Simonson MD, MPH, Sc D

Authors
  1. Jeremy J. Cook DPM, MPH, CPH, FACFAS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Donald C. Simonson MD, MPH, Sc D
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jeremy J. Cook DPM, MPH, CPH, FACFAS .

Editor information

Editors and Affiliations

  1. Center, Department of Surgery, Beth Israel Deaconess Medical, 1 Deaconess Road, Boston, 02215, Massachusetts, USA

    Aristidis Veves

  2. , Division of Podiatry, Beth Israel Deaconess Medical Center, 1 Deaconess Road, Boston, 02215, Massachusetts, USA

    John M. Giurini

  3. Center, Department of Surgery, Beth Israel Deaconess Medical, 110 Francis Street, Boston, 02215, Massachusetts, USA

    Frank W. LoGerfo

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Cook, J.J., Simonson, D.C. (2012). Epidemiology and Health Care Cost of Diabetic Foot Problems. In: Veves, A., Giurini, J., LoGerfo, F. (eds) The Diabetic Foot. Contemporary Diabetes. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-791-0_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-61779-791-0_2

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61779-790-3

  • Online ISBN: 978-1-61779-791-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation